This inventor holds 44 USPTO granted patents and 20 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Immunomodulatory Proteins. Top assignees: Zymogenetics, Inc., Alpine Immune Sciences, Inc., University of Washington. Active years: 1998-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bothell, WA (US) (1998 - 1999)
- Bagsvaerd, DK (2017 - 2018)
- Kenmore, WA (US) (2006 - 2023)
- Seattle, WA (US) (2022 - 2023)
Company Filing History:
27 out of 723 
14 out of 29 
3 out of 2,172 
Years Active: 1998-2026
Areas of Expertise:
Title: Innovations of Joseph Leon Kuijper in Immunomodulatory Proteins
Introduction
Joseph Leon Kuijper is a notable inventor based in Kenmore, Washington, with an impressive portfolio of 41 patents. His work primarily focuses on immunomodulatory proteins that have significant therapeutic implications for various diseases and conditions.
Latest Patents
Among his latest innovations are two remarkable patents. The first is associated with APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof. This patent describes proteins that exhibit neutralizing activity against BAFF and APRIL, including important variants of Transmembrane Activator and CAML Interactor (TACI). Notably, these proteins include TACI-Fc fusion proteins and elucidate the therapeutic utility for a range of immunological diseases and disorders. The second patent focuses on CD112 variant immunomodulatory proteins, emphasizing their utility in treating both immunological and oncological conditions. It also provides compositions and methods for the development and application of these innovative proteins.
Career Highlights
Joseph has made remarkable contributions to his field while working at renowned companies such as Zymogenetics, Inc. and Alpine Immune Sciences, Inc. His work in these organizations has paved the way for advancements in immunotherapy, enhancing the treatment options available for patients suffering from various ailments.
Collaborations
Collaboration plays a crucial role in the innovation process, and Joseph has worked alongside esteemed coworkers, including Cindy A Sprecher and Francis J Grant. Their combined efforts in research have undoubtedly contributed to the successful development of groundbreaking immunomodulatory therapies.
Conclusion
Joseph Leon Kuijper's contributions to the field of immunology through his patents highlight his innovative spirit and dedication to enhancing healthcare solutions. With a robust portfolio and a commitment to research and collaboration, he continues to pave the way for future advancements in the treatment of immunological and oncological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile